在急性中风管理中,基于尿液的XA因子抑制剂的治疗点检测
Prasen R Marella1, Jacob A Sambursky1, Kriti Bhayana1
1Department of Neurology, University of Texas-McGovern Medical School, Houston TX, USA.
概括
对直接作用的口服抗凝剂 (DOAC) 活性进行新的尿液测试是可行的和准确的. 这种护理点测试可以帮助指导潜在使用DOAC的中风患者的紧急治疗决策.
科学领域:
- 临床化学 临床化学
- 紧急医疗 紧急医疗
- 药理学 药理学是指药理学的学科.
背景情况:
- 直接作用的口服抗凝剂 (DOACs) 在急性中风患者中,由于抗凝状态不明,造成治疗挑战.
- 需要快速点诊测试来指导紧急治疗决策.
研究的目的:
- 评估一种基于尿液的新型临床点检测试验的可行性和准确性,以检测Xa因子抑制剂 (Xai) 活性.
- 评估尿液测试对急性中风患者临床管理的潜在影响.
主要方法:
- 预期招募急性中风患者,怀疑最近使用Xa因子抑制剂 (Xai).
- 同时收集尿液测试和血抗Xa水平.
- 记录了临床管理决策,而不知道尿液检测结果.
主要成果:
- 在所有被录取的患者中,尿液测试是可行的,平均周转时间为59分钟.
- 该测试显示了检测值抗Xa活性 (>30 ng/mL) 的高灵敏度 (100%) 和特异性 (87.5%).
- 阴性尿检结果将表明66%符合条件的缺血性中风患者的治疗.
结论:
- 在紧急情况下,尿液检测Xai活性是可行的和准确的.
- 这项测试有可能使中风患者的血栓抑制治疗成为可能,目前由于不确定的抗凝血状态而被排除在外.
相关概念视频
Venous Thrombosis III: Interprofessional Care
268
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
268
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
286
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
286


